This Terns Pharmaceuticals Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Monday

Benzinga·03/30/2026 14:23:28

Listen to the news

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Citigroup analyst Scott Gruber downgraded Ovintiv Inc. (NYSE:OVV) from Buy to Neutral and raised the price target from $52 to $62. Ovintiv shares closed at $62.08 on Friday. See how other analysts view this stock.
Barclays analyst Etzer Darout downgraded Terns Pharmaceuticals, Inc. (NASDAQ:TERN) from Overweight to Equal-Weight and lowered the price target from $56 to $53. Terns Pharma shares closed at $52.92 on Friday. See how other analysts view this stock.
Wedbush analyst Michael Piccolo downgraded Burford Capital Limited (NYSE:BUR) from Outperform to Neutral and cut the price target from $6 to $4.75. Burford Capital shares closed at $4.14 on Friday. See how other analysts view this stock.
Raymond James analyst Jayson Bedford downgraded Boston Scientific Corporation (NYSE:BSX) from Strong Buy to Outperform and lowered the price target from $97 to $88. Boston Scientific shares closed at $69.17 on Friday. See how other analysts view this stock.

Considering buying OVV stock? Here’s what analysts think:

Photo via Shutterstock

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Contact Number :+852 3852 8500

Monday 7:00 AM - Saturday 9:00 AM (HKT)

Service Email :service@webull.hk

Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)

Business Cooperation :marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English